Finance

Lists
Why is ELOX down 2.67%?
Dive Deeper
ELOX:NASDAQ
Eloxx Pharmaceuticals Inc
$10.59
-2.67%
(-0.29) 1D
Nov 20, 3:15:26 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELOX...
Open
$10.90
High
$10.94
Low
$9.90
Mkt. cap
43.28M
Avg. vol.
24.99K
Volume
11.91K
52-wk high
$23.40
52-wk low
$8.20
Beta
3.58
Shares outstanding
4.09M
No. of employees
10
Open
$10.90
High
$10.94
Low
$9.90
Mkt. cap
43.28M
Avg. vol.
24.99K
Volume
11.91K
52-wk high
$23.40
52-wk low
$8.20
Beta
3.58
Shares outstanding
4.09M
No. of employees
10
News stories
From web sources and news partners
About Eloxx Pharmaceuticals Inc
CEO-
Employees10
Founded1999
HeadquartersWatertown, Massachusetts, United States
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to ELOX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ELOX in the last 3 months.
Highest
Current $10.59
$40.00 (+277.71%)
Average
$36.00 (+239.94%)
Lowest
$32.00 (+202.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Schwartz
Leerink Partners
Buy
Reiterated
$32.00
+202.2%
11/17/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$40.00
+277.7%
10/27/2026
Yanni Souroutzidis
Cantor Fitzgerald
Buy
Initiated
-
-
10/15/2026
Dev Prasad
Lucid Capital
Buy
Initiated
$38.00
+258.8%
08/20/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$40.00
+277.7%
08/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-250.00K
1.66M
2.84M
4.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
535.00K
2.14M
1.61M
1.92M
Operating expense
285.00K
3.80M
4.45M
5.95M
Total operating expenses
285.00K
3.80M
4.45M
5.95M
Operating income
-285.00K
-3.80M
-4.45M
-5.95M
Other non operating income
-66.00K
-9.00K
-85.00K
410.00K
EBT including unusual items
-351.00K
-3.75M
-4.50M
-5.54M
EBT excluding unusual items
-351.00K
-3.81M
-4.50M
-5.54M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-351.00K
-3.75M
-4.50M
-5.54M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
23.00K
41.00K
-
Interest expense
-
-29.00K
-8.00K
-
Net interest expenses
-
-6.00K
33.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-276.25K
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps